| 产品描述: | CB2R PAM 是一种具有口服活性大麻素 2 型受体 (CB2Rs) 正向变构调节剂。CB2R PAM 在神经病理性疼痛小鼠模型中显示抗伤害活性。 |
| 靶点: |
cannabinoid type-2 receptors |
| 体外研究: |
CB2R PAM (100 nM) significantly enhances the ability of CP55940 and 2-AG, but not of AEA, to stimulate [35S]GTPγS binding to CB2Rs. |
| 体内研究: |
CB2R PAM (1-20 mg/kg; p.o.) displays antinociceptive activity. |
| 参考文献: |
1. Gado F, et al. Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief. J Med Chem. 2019;62(1):276-287. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.297 ml |
11.486 ml |
22.971 ml |
| 5 mM |
0.459 ml |
2.297 ml |
4.594 ml |
| 10 mM |
0.23 ml |
1.149 ml |
2.297 ml |
| 50 mM |
0.046 ml |
0.23 ml |
0.459 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |